Biosupply Trends Marketplace News
Monday, June 17, 2019
biosupply button green pixel top of biosupply button
Biosupply, place your product order MyFluVaccine, place your vaccine order Verified Inventory Program, sign up for streamlined inventory

Connecting with People Who Have Suffered from Diseases Can Change Attitudes Toward Vaccines

Main article image
 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 

A study that tested whether vaccine-hesitant students who may be unfamiliar with the consequences of vaccine-preventable diseases (VPDs) might be swayed when confronted with the symptoms and dangers of VPDs found introducing them to people affected by VPDs can decrease vaccine hesitancy. [ read more ]

Campaign Launched to Remind Families Teens Need Second Meningitis Booster Shot

In response to Centers for Disease Control and Prevention data that shows more than half of teens have not received the second recommended dose of the meningicoccal meningitis vaccine, the National Meningitis Association has launched "16 Vaccine." The new educational campaign encourages more teens to get vaccinated with the booster dose to prevent meningitis. [ read more ]

Informatics Could Help Diagnose PI and Save Money

A recent study shows population-wide informatics can help in detecting primary immunodeficiency disease (PI) and improve outcomes, thus saving money. [ read more ]

Industry News

 
Industry News Image
 

From Octapharma

The U.S. Food and Drug Administration has approved a revised product label for Octapharma USA's Octaplas (pooled plasma [human] solvent/detergent treated solution for intravenous infusion) to treat critically ill pediatric patients who require replacement of multiple coagulation factors. [ read more ]

From Jacobus Pharmaceutical Company

Ruzurgi (amifampridine) tablets to treat Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 years to less than 17 years of age have been approved by the U.S. Food and Drug Administration. This is the first FDA approval of a treatment specifically for pediatric patients with LEMS.  [ read more ]

From ADMA Biologics

The U.S. Patent and Trademark Office has issued a patent to ADMA Biologics for methods of treatment and prevention of S. pneumonia infection.  [ read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Days On Hand
 
Log in to BioSupply for IVIG and Albumin Product Pricing
 

What's New at FFF

FIBRYGA  (OCTAPHARMA USA)

FIBRYGA is a human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. It is not indicated for dysfibrinogenemia. FIBRYGA packages include one single-use bottle of FIBRYGA concentrate, one transfer device (Octajet) and one particle filter.

For more information about FIBRYGA, login to biosupply.fffenterprises.com

JIVI  (BAYER HEALTHCARE)

JIVI (antihemophilic factor [recombinant], PEGylated-aucl) is a recombinant DNA-derived Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for 1) on-demand treatment and control of bleeding episodes, 2) perioperative management of bleeding and 3) routine prophylaxis to reduce the frequency of bleeding episodes. JIVI is available as a lyophilized powder in single-use glass vials, one vial per carton. It is supplied with a sterile vial adapter with a 15-micrometer filter and a prefilled diluent glass barrel syringe, that together serve as a needleless reconstitution system.

For more information about JIVI, login to biosupply.fffenterprises.com

ANDEXXA®  (PORTOLA)

ANDEXXA [coagulation factor Xa (recombinant), inactivated-zhzo] is the first and only antidote indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. It is supplied in cartons of four single-use vials containing 100 mg of ANDEXXA as a white to off-white lyophilized cake or powder.

For more information about ANDEXXA, login to biosupply.fffenterprises.com

LidoDose®  (GENSCO PHARMA)

Prepare your patients for a less painful flu season with LidoDose, the single dose™ topical anesthetic and antiseptic for preprocedural preparation of the skin prior to an injection and pain associated with any procedure requiring penetration of the skin, including vaccinations.

For more information about LidoDose, login to biosupply.fffenterprises.com

ALBUMINEX®  (BIO PRODUCTS LABORATORY)

ALBUMINEX [Human 5% and 25%], prepared from the pooled plasma of U.S. donors in FDA-licensed facilities in the U.S., comes in 5% and 25% albumin solutions indicated for adults and children for hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome and cardipulmonary bypass. ALBUMINEX 5% is supplied in 12.5 g and 25 g single-dose vials. ALBUMINEX 25% is supplied in 50 mL and 100 mL single-dose vials.

For more information about ALBUMINEX, login to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective April 1, 2019, through June 30, 2019.

 
Calculate your current medicare IVIG/SCIG Rates
Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
IVIG
Flebogamma J1572 $72.85 $71.68
Gammagard S/D J1566 $119.62 $117.70
Gammaplex J1557 $88.40 $86.98
Octagam J1568 $64.94 $63.90
Privigen J1459 $81.44 $80.13
SCIG
CUVITRU J1555 $131.69 $129.58
Hizentra J1559 $101.94 $100.31
HyQvia J1575 $141.09 $138.83
IVIG / SCIG
Gammagard Liquid J1569 $84.31 $82.96
Gammaked J1561 $77.50 $76.25
Gamunex-C J1561 $77.50 $76.25

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

 
Log in to BioSupply for Immune Globulin Products

Resources

FFF customers may order the following complementary resources to help you with your practice:

Seasonal Flu Poster flu myths and facts brochure
immune globulin reference charts
•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to IG Living
IG Living Magazine cover
BioSupplyTrends Quarterly Magazine cover

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Subscribe to Biosupply Trends Quarterly Magazine
small Biosupply logo small MyFluVaccine logo Verified Inventory Program logo
Home | About | Advertise | Subscribe | Contact – ©2019 FFF Enterprises, Inc.